Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NuGen's Ovation Fusion Panel

Premium

NuGen has launched Ovation Fusion Panel Target Enrichment System, an assay that will detect all possible fusion events involving 446 cancer fusion genes. The assay uses NuGen's proprietary Single Primer Enrichment Technology, a single primer strategy that requires only one partner exon to be targeted, which enables detection of both known and novel fusion events, as well as alternative isoforms, according to the company. It requires 10 ng of total RNA from either fresh frozen or formalin-fixed paraffin-embedded tissue.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.